Embryonic Ploidy Status in the Oncofertility Population

Completed

Conditions studied: Oncology, Fertility

In brief

looking at aneuploidy rates in embryos from patients who are going to or have undergone treatment for a malignancy with gonadotoxic treatment.

Key facts

Study ID

NCT03350230

Run by

Reproductive Medicine Associates of New Jersey

People needed

30

Starts

2017-12-01

Expected to finish

2022-07-21

Last updated by the study team

2023-05-03

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Present or past oncologic diagnosis requiring potentially gonadotoxic treatment

You may not qualify if…

• Oocyte banking
• Use of oocyte donation
• Any contraindications to undergoing in vitro fertilization or gonadotropin stimulation
• Single gene disorder requiring more detailed embryo genetic analysis

Where it is running

• Reproductive Medicine Associates of New Jersey — Basking Ridge, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.